Shigeta Yasumitsu 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-11 4:15 pm Sale | 2020-07-16 | 13G | Akari Therapeutics, Plc AKTX | Shigeta Yasumitsu | 0 0.000% | -75,005 (Position Closed) | Filing |